Literature DB >> 27817235

[Psoriasis and oxidative stress].

Iván Péter1, Anna Jagicza1, Zénó Ajtay1,2, István Kiss3, Balázs Németh1,3.   

Abstract

Psoriasis is among the most common dermatological diseases worldwide. Its significance is emphasized by adverse effects on quality of life, caused by chronic pain, physical and psychical disability due to psoriatic plaques. Besides the development of psoriatic arthritis, which often causes permanent joint damage, former studies revealed an increased risk of inflammatory bowel disease, cardiovascular disease and certain types of cancer. Genetic predisposition and oxidative stress caused by exogenous and endogenous factors can contribute to abnormal differentiation and hyperproliferation of keratinocytes, accordingly the development and maintenance of psoriasis. Moreover, excessive oxidative stress can be responsible for the onset of psoriasis complications. After a brief pathophysiological summary the authors discuss the role of oxidative stress in the development of psoriasis and its complications through several well studied biomarkers (asymmetric dimethylarginine, malondialdehyde, superoxide dismutase, catalase). Orv. Hetil., 2016, 157(45), 1781-1785.

Entities:  

Keywords:  biomarker; oxidative stress; oxidatív stressz; psoriasis

Mesh:

Year:  2016        PMID: 27817235     DOI: 10.1556/650.2016.30589

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  9 in total

1.  Balneotherapy in Psoriasis Rehabilitation.

Authors:  Iván Péter; Anna Jagicza; Zénó Ajtay; Imre Boncz; István Kiss; Katalin Szendi; Péter Kustán; Balázs Németh
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

2.  Urinary Orosomucoid A Potential Marker Of Inflammation In Psoriasis.

Authors:  Péter Kustán; Tamás Kőszegi; Attila Miseta; Iván Péter; Zénó Ajtay; István Kiss; Balázs Németh
Journal:  Int J Med Sci       Date:  2018-07-13       Impact factor: 3.738

Review 3.  Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation.

Authors:  Fengli Xu; Jixiang Xu; Xia Xiong; Yongqiong Deng
Journal:  Redox Rep       Date:  2019-12       Impact factor: 4.412

4.  Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?

Authors:  Balázs Németh; Iván Péter; Imre Boncz; Anna Jagicza; István Kiss; Ágnes Csergő; Tamás Kőszegi; Péter Kustán; Iván G Horváth; Zénó Ajtay
Journal:  Ther Clin Risk Manag       Date:  2019-07-05       Impact factor: 2.423

5.  Metabolomics-Based Profiling, Antioxidant Power, and Uropathogenic Bacterial Anti-Adhesion Activity of SP4TM, a Formulation with a High Content of Type-A Proanthocyanidins.

Authors:  Giuseppe Mannino; Massimo E Maffei
Journal:  Antioxidants (Basel)       Date:  2022-06-23

6.  An Emerging Role of Proanthocyanidins on Psoriasis: Evidence from a Psoriasis-Like Mouse Model.

Authors:  Yang Yang; Yangmeng Zhao; Rui Lai; Li Xian; Qirong Lei; Jixiang Xu; Menglu Guo; Dehai Xian; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

7.  The protective effect of proanthocyanidins on the psoriasis-like cell models via PI3K/AKT and HO-1.

Authors:  Yangmeng Zhao; Yuxin Xie; Xiaolong Li; Jing Song; Menglu Guo; Dehai Xian; Jianqiao Zhong
Journal:  Redox Rep       Date:  2022-12       Impact factor: 5.696

Review 8.  Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells.

Authors:  Rui Lai; Dehai Xian; Xia Xiong; Lingyu Yang; Jing Song; Jianqiao Zhong
Journal:  Redox Rep       Date:  2018-12       Impact factor: 4.412

9.  The relationship of ischemia-modified albumin levels to disease activity scores and HLA-B27 in patients with ankylosing spondylitis.

Authors:  Filiz Meryem Sertpoyraz; Ayfer Colak; Aylin Dikici; Nihan Erdinc Gunduz; Merve Zeytinli Aksit
Journal:  North Clin Istanb       Date:  2020-11-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.